Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,171
datasets available to search
ShareScore release 0.9.0
Dataset results
6,171 results for “mutant”
Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC
ClinicalTrials.gov study NCT06613633. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI
ClinicalTrials.gov study NCT05601973. IPD Sharing: YES. Countries: 6. Publications: 0.
Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT05932667. IPD Sharing: YES. Countries: 1. Publications: 0.
A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma
ClinicalTrials.gov study NCT06342908. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TLN-372 in Advanced KRAS Mutant Solid Tumors
ClinicalTrials.gov study NCT07204340. IPD Sharing: NO. Countries: 2. Publications: 0.
A Study of Famitinib in Combination With HS-10296 in Patients With EGFR-mutant NSCLC
ClinicalTrials.gov study NCT03904823. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid Tumor
ClinicalTrials.gov study NCT05814536. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Apatinib and Fluzoparib With or Without Adebrelimab in Previously-treated TP53-mutant Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT05932264. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase I of Vorinostat-Iressa Combined Therapy on Resistance by BIM Polymorphysim in EGFR Mutant Lung Cancer
ClinicalTrials.gov study NCT02151721. IPD Sharing: YES. Countries: 1. Publications: 0.
Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II Trial
ClinicalTrials.gov study NCT06363734. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT07017829. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II Study of AMG 510 in Combination With MVASI in Patients With Advanced, Unresectable or Metastatic KRAS G12C Mutant NSCLC With Asymptomatic Brain Metastasis
ClinicalTrials.gov study NCT05180422. IPD Sharing: NO. Countries: 1. Publications: 0.
Adjuvant Targeted-therapy for Patients With Resected High-risk EGFR-mutant Stage IB-IIA Non-small Cell Lung Carcinoma
ClinicalTrials.gov study NCT05165355. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06890598. IPD Sharing: YES. Countries: 29. Publications: 0.
Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT04132505. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers
ClinicalTrials.gov study NCT06194877. IPD Sharing: YES. Countries: 2. Publications: 0.
Neoadjuvant Sacituzumab Tirumotecan and Limertinib for Potentially Resectable Stage Ⅲ EGFR-mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT07323056. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma
ClinicalTrials.gov study NCT07240662. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lapatinib Plus Trametinib in KRAS Mutant NSCLC
ClinicalTrials.gov study NCT02230553. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Furmonertinib in EGFR-Mutant, PD-L1+ Patients With Locally Advanced or Metastatic NSCLC (FUTURE)
ClinicalTrials.gov study NCT05255406. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.